Clinical Trial

Spirulina-Derived Product Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
To evaluate the efficacy and safety of Spirulina-Derived Product for prevention and treatment of oral mucositis in patients undergoing radiotherapy for malignant head and neck tumors.
Protocol Amendment History 2 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-04-08
minor Completion pushed: 2026-01-31 -> 2026-04-30 2026-04-08
Trial Details
NCT Number NCT07040969
Lead Sponsor West China Hospital
Conditions Radiation-induced Oral Mucositis
Enrollment 70 participants
Start Date 2025-06-27
Primary Completion 2026-01-15 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-07